Abstract: Illness states are reported to create disparate data sets associated with illness reports. The illness reports are verified by comparing and correlating information in the data sets. Illness reports are indicated by location-specific markers displayed on a map of a particular geographical region of interest by a computing device having a display screen. Illness reports having associated data in both data sets are considered to be verified, and thus to have a higher level of relevance as more reliable, more persuasive, more severe, and/or more accurate. Verification indicators are displayed on the display screen in association with each marker for which the associated illness report has been verified. Accordingly, reported illnesses are displayed on a geographically-relevant basis in differentiated fashion to provide a visual indication of verified and unverified reported illnesses.

Abstract: Illness states are reported to create disparate data sets associated with illness reports. The illness reports are verified by comparing and correlating information in the data sets. Illness reports are indicated by location-specific markers displayed on a map of a particular geographical region of interest by a computing device having a display screen. Illness reports having associated data in both data sets are considered to be verified, and thus to have a higher level of relevance as more reliable, more persuasive, more severe, and/or more accurate. Verification indicators are displayed on the display screen in association with each marker for which the associated illness report has been verified. Accordingly, reported illnesses are displayed on a geographically-relevant basis in differentiated fashion to provide a visual indication of verified and unverified reported illnesses.

Abstract: The present invention relates to a lipopolysaccharide moiety comprising a conserved triheptosyl inner-core moiety of lipopolysaccharide substantially free of variable outer core oligosaccharide chain extension, and to vaccines obtaines therefrom which are cross-reactive for Haemophilus influenzae strains. The invention also relates to defined mutations in the biosynthetic machinery for lipopolysaccharide (LPS;) expression in Haemophilus influenzae useful to obtain the abovementioned moiety. The invention also relates to using conjugates of the LPS from the mutant strains so obtained to elicit a heterologous immune response against a wide range of disease-causing H. influenzae strains. More specifically, the invention relates to vaccines for prevention of bacterial infections comprising core lipopolysaccharide of Haemophilus influenzae.

Abstract: The present invention relates to a lipopolysaccharide moiety comprising a conserved triheptosyl inner-core moiety of lipopolysaccharide substantially free of variable outer core oligosaccharide chain extension, and to vaccines obtaines therefrom which are cross-reactive for Haemophilus influenzae strains. The invention also relates to defined mutations in the biosynthetic machinery for lipopolysaccharide (LPS;) expression in Haemophilus influenzae useful to obtain the abovementioned moiety. The invention also relates to using conjugates of the LPS from the mutant strains so obtained to elicit a heterologous immune response against a wide range of disease-causing H. influenzae strains. More specifically, the invention relates to vaccines for prevention of bacterial infections comprising core lipopolysaccharide of Haemophilus influenzae.